HRMY vs MRNA · P/E 14, rev $476.7M vs rev $145.0M
Harmony Biosciences Holdings (HRMY) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Harmony Biosciences Holdings (HRMY) is a biotechnology company listed on NASDAQ.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Latest reported HRMY revenue for 2026-06-30 was $476.7M. Net income was $107.9M. HRMY currently screens at market cap $1.96B and trailing P/E 13.6.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
HRMY currently screens at market cap $1.96B and trailing P/E 13.6. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the HRMY and MRNA stock pages for the full models.
Not investment advice.